第十三届中国宫颈癌防治工程学术年会在沪召开

Group 1 - The 13th China Cervical Cancer Prevention Engineering Academic Annual Conference was held in Shanghai, focusing on key issues such as cervical cancer prevention, basic research, HPV vaccines, screening, and treatment [1][2] - The conference theme was "Precise Prevention and Treatment, Integrated Innovation - Accelerating the Elimination of Cervical Cancer," aiming to enhance gynecological diagnosis and treatment levels in grassroots medical institutions [2][3] - The "90-70-90" cervical cancer prevention target was highlighted, indicating the need for continued efforts to explore optimal prevention paths suitable for China's national conditions [2][3] Group 2 - The Pat Bio Group, a subsidiary of Pat Ling, won the "Social Responsibility Award" at the conference, marking its continuous recognition for over thirty years in the field [1][3] - The conference served as a significant platform for summarizing and exchanging annual viewpoints on cervical cancer and HPV prevention, linking social and medical forces, and integrating advantages from different disciplines [3] - Emphasis was placed on breaking down disciplinary barriers and fostering innovative concepts in cervical cancer prevention, aligning with technological advancements [3]